BTS Abstract_M MacFarlane_Reconfigured 070308.pdf (32.95 kB)
Receptor-selective TRAIL Mutants Target Lymphoid Tumor cells for Apoptosis via TRAIL-R1: Implications for Therapy.
journal contribution
posted on 2009-02-04, 10:12 authored by Marion MacFarlane, Susan Louise Kohlhaas, Michael J. Sutcliffe, Martin J. S. Dyer, Gerald M. CohenReceptor-selective TRAIL Mutants Target Lymphoid Tumor cells for Apoptosis via TRAIL-R1: Implications for Therapy.